Teen Marijuana E-cigarette Use Doubles in the US and Canada

May.07.2022
Teen Marijuana E-cigarette Use Doubles in the US and Canada
Teen vaping of cannabis e-cigarettes has doubled since 2013, reaching 13.6% in 2020, while smoking rates continue to decline.

According to a recent study published in JAMA Pediatrics, the prevalence of marijuana e-cigarette use among teenagers has doubled from 2013 to 2020. In 2018 alone, approximately one-third of 12th-grade students consumed marijuana.


A commentary has analyzed 17 studies conducted in the United States and Canada between 2015 and 2021, involving a total of 198,845 surveyed adolescents. Titled "Prevalence of adolescent marijuana and e-cigarette use: A systematic review and meta-analysis of US and Canadian studies," the analysis found that the lifetime prevalence of marijuana e-cigarette use rose from 6.1% in 2013 to 13.6% in 2020. Furthermore, between 2017 and 2020, the prevalence of marijuana e-cigarette use doubled, increasing from 7.2% to 13.2%. Additionally, from 2013 to 2020, the 30-day prevalence increased by 7 times, from 1.6% to 8.4%.


According to the author, one possible explanation for the observed increase in popularity of cannabis e-cigarette use within the time frame studied is the expansion of opportunities to acquire cannabis e-cigarette products, particularly among young people who commonly use e-cigarette products. This expansion is thought to be driven, in part, by the legalization of cannabis, which has reduced the perceived risk associated with its use over the last decade.


Smoking rates have decreased.


Meanwhile, a recent tobacco and nicotine survey in Canada showed that smoking rates for this particular age group decreased by 40% from 13.3% to 8% between 2019-2020. This figure is encouraging for Canada's Health Department's goal of a 5% smoking prevalence rate by 2035. Additionally, the 15-19 age group has already achieved this target, with current smoking rates not exceeding 5%.


In a letter to Patty Hajdu, the Minister of Health and an economics professor and medical researcher at Concordia University, Ian Irvine of the Howe Institute expressed disappointment about the media's selective coverage of vaping-related issues. Irvine stated that the media has largely overlooked important accomplishments in this field and instead has focused on the concept of vaping as a popular trend among this age group.


Irvine emphasized that although smoking rates have been decreasing due to government policies on tobacco, a true change occurred with the emergence of e-cigarette products. "By 2013, the smoking rate among the 15-19 age group had dropped to 11%, 18% among the 20-24 age group, and 16% among those 25 and older...then a disruptive technology appeared - e-cigarettes.


Source: Vaping Post.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Marty Makary briefly appeared at the February 10 PMTA roundtable, underscoring the importance of regulatory predictability. At the close of the session, Office of Science Director Matthew Farrelly responded to industry concerns over review uncertainty, stating the agency will issue a written summary of feedback, while reiterating that no fixed quantitative risk benchmark governs authorization decisions.
Feb.11
Azerbaijan Imposes Comprehensive E-Cigarette Ban Covering Import, Export, Sales and Use, Effective April 1
Azerbaijan Imposes Comprehensive E-Cigarette Ban Covering Import, Export, Sales and Use, Effective April 1
Azerbaijan has approved amendments to its tobacco law that introduce a comprehensive ban on e-cigarettes and their components, covering import, export, production, storage, wholesale and retail sales, and use. Nicotine-containing e-cigarettes are classified as tobacco products under the revised framework. The law takes effect on April 1, 2026.
Jan.27 by 2FIRSTS.ai
BAT’s Vuse Ultra listed as GOOD DESIGN Awards winner; features app connectivity and adjustable intensity
BAT’s Vuse Ultra listed as GOOD DESIGN Awards winner; features app connectivity and adjustable intensity
British American Tobacco’s (BAT) Vuse Ultra vaping product has been listed among winners on the U.S. GOOD DESIGN Awards website, in the “Personal Experience” category, according to the project page. The page identifies the award year as 2025 and names BAT (London) as both the entrant and the manufacturer.
Jan.20 by 2FIRSTS.ai
Virginia HB 308 would overhaul tobacco and nicotine rules, and creating a vape “white list”
Virginia HB 308 would overhaul tobacco and nicotine rules, and creating a vape “white list”
Virginia’s HB 308 (Substitute) proposes a sweeping rewrite of how tobacco, nicotine and certain smokable hemp products are regulated, consolidating enforcement under ABC, requiring retailer permits, creating a vape product directory and escalating penalties for violations.
Feb.06 by 2FIRSTS.ai
Bangladesh enforces a complete ban on e-cigarettes and emerging tobacco products, with jail and heavy fines
Bangladesh enforces a complete ban on e-cigarettes and emerging tobacco products, with jail and heavy fines
UNB reports that Bangladesh has imposed a complete ban on e-cigarettes, vapes, and other emerging tobacco products as the Smoking and Tobacco Products Use Control (Amendment) Ordinance, 2025 has come into effect.
Jan.04 by 2FIRSTS.ai
Philippine FDA Requires Licenses for Vape Products with Medical Claims
Philippine FDA Requires Licenses for Vape Products with Medical Claims
The Philippine Food and Drug Administration has announced that establishments selling vaporized nicotine and non-nicotine products and novel tobacco products with medicinal or therapeutic claims must secure Licenses to Operate. Such products are also required to be registered as pharmaceutical products through the Center for Drug Regulation and Research. The FDA urged stakeholders to comply with the new requirements to ensure product safety, efficacy and quality.
Dec.22 by 2FIRSTS.ai